KRONOS WORLDWIDE INC - Quarter Report: 2009 March (Form 10-Q)
UNITED
STATES
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
|
Washington,
D.C. 20549
|
|
FORM
10-Q
|
|
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
|
|
For
the quarter ended March 31,
2009
|
|
Commission
file number 1-31763
|
|
KRONOS WORLDWIDE, INC.
|
|
(Exact
name of Registrant as specified in its charter)
|
|
DELAWARE
|
76-0294959
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer Identification No.)
|
5430
LBJ Freeway, Suite 1700
|
|
Dallas,
Texas 75240-2697
|
|
(Address
of principal executive offices)
|
|
Registrant's
telephone number, including area
code: (972) 233-1700
|
|
Indicate
by check mark whether the Registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months and (2) has been subject to such filing requirements for the
past 90 days. Yes X No
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding
12 months (or for such shorter period that the registrant was required to submit
and post such files).* Yes No
*
|
The
registrant has not yet been phased into the interactive data
requirements
|
Indicate
by check mark whether the Registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting company (as
defined in Rule 12b-2 of the Securities Exchange Act of 1934). Large
accelerated filer Accelerated
filer
Non-accelerated filer X Smaller
reporting company
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule
12b-2 of the Act). Yes No
X
Number
of shares of the Registrant's common stock outstanding on April 30, 2009:
48,960,049.
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
INDEX
Page
|
||
number
|
||
Part
I.
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements
|
|
Condensed
Consolidated Balance Sheets -
|
||
December
31, 2008; March 31, 2009 (Unaudited)
|
3
|
|
Condensed
Consolidated Statements of Operations (Unaudited) -
|
||
Three
months ended March 31, 2008 and 2009
|
5
|
|
Condensed
Consolidated Statement of Stockholders'
|
||
Equity
and Comprehensive Income (Loss) (Unaudited) –
|
||
Three
months ended March 31, 2009
|
6
|
|
Condensed
Consolidated Statements of Cash Flows (Unaudited) -
|
||
Three
months ended March 31, 2008 and 2009
|
7
|
|
Notes
to Condensed Consolidated Financial Statements (Unaudited)
|
8
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial
|
|
Condition
and Results of Operations
|
17
|
|
Item
3.
|
Quantitative
and Qualitative Disclosure About Market Risk
|
26
|
Item
4.
|
Controls
and Procedures
|
26
|
Part
II.
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
28
|
Item
1A.
|
Risk
Factors
|
28
|
Item
6.
|
Exhibits
|
28
|
Items
2, 3, 4 and 5 of Part II are omitted because there is no information to
report.
|
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED BALANCE SHEETS
(In
millions)
ASSETS
|
December
31,
|
March
31,
|
||||||
2008
|
2009
|
|||||||
(Unaudited)
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 13.6 | $ | 27.6 | ||||
Restricted
cash
|
1.5 | 1.0 | ||||||
Accounts
and other receivables
|
178.6 | 187.5 | ||||||
Inventories
|
385.1 | 294.6 | ||||||
Prepaid
expenses and other
|
6.6 | 9.1 | ||||||
Deferred
income taxes
|
4.1 | 4.1 | ||||||
Total
current assets
|
589.5 | 523.9 | ||||||
Other
assets:
|
||||||||
Investment
in TiO2
manufacturing joint venture
|
105.6 | 107.4 | ||||||
Deferred
income taxes
|
166.4 | 178.5 | ||||||
Other
|
11.7 | 11.2 | ||||||
Total
other assets
|
283.7 | 297.1 | ||||||
Property
and equipment:
|
||||||||
Land
|
37.5 | 36.3 | ||||||
Buildings
|
215.9 | 210.6 | ||||||
Equipment
|
949.8 | 928.0 | ||||||
Mining
properties
|
73.9 | 79.4 | ||||||
Construction
in progress
|
41.7 | 48.9 | ||||||
1,318.8 | 1,303.2 | |||||||
Less
accumulated depreciation and amortization
|
833.3 | 829.7 | ||||||
Net
property and equipment
|
485.5 | 473.5 | ||||||
Total
assets
|
$ | 1,358.7 | $ | 1,294.5 | ||||
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(In
millions)
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
December
31,
2008
|
March
31,
2009
|
||||||
(Unaudited)
|
||||||||
Current
liabilities:
|
||||||||
Current
maturities of long-term debt
|
$ | .8 | $ | 69.7 | ||||
Accounts
payable and accrued liabilities
|
195.3 | 136.6 | ||||||
Income
taxes
|
3.7 | 5.8 | ||||||
Deferred
income taxes
|
4.6 | 4.4 | ||||||
Total
current liabilities
|
204.4 | 216.5 | ||||||
Noncurrent
liabilities:
|
||||||||
Long-term
debt
|
637.7 | 587.6 | ||||||
Deferred
income taxes
|
35.7 | 40.3 | ||||||
Accrued
pension cost
|
125.5 | 118.6 | ||||||
Accrued
postretirement benefit cost
|
8.7 | 8.7 | ||||||
Other
|
28.8 | 28.4 | ||||||
Total
noncurrent liabilities
|
836.4 | 783.6 | ||||||
Stockholders'
equity:
|
||||||||
Common
stock
|
.5 | .5 | ||||||
Additional
paid-in capital
|
1,061.8 | 1,061.8 | ||||||
Retained
deficit
|
(567.9 | ) | (594.5 | ) | ||||
Accumulated
other comprehensive loss
|
(176.5 | ) | (173.4 | ) | ||||
Total
stockholders' equity
|
317.9 | 294.4 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 1,358.7 | $ | 1,294.5 |
Commitments
and contingencies (Notes 7 and 10)
See
accompanying Notes to Condensed Consolidated Financial Statements.
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In
millions, except per share data)
Three
months ended
March 31,
|
||||||||
2008
|
2009
|
|||||||
(Unaudited)
|
||||||||
Net
sales
|
$ | 332.5 | $ | 248.0 | ||||
Cost
of sales
|
275.4 | 243.9 | ||||||
Gross
margin
|
57.1 | 4.1 | ||||||
Selling,
general and administrative expense
|
43.3 | 34.3 | ||||||
Currency
transaction gains (losses), net
|
(2.5 | ) | 5.3 | |||||
Other
operating income (expense), net
|
(1.6 | ) | (1.4 | ) | ||||
Income
(loss) from operations
|
9.7 | (26.3 | ) | |||||
Other
income (expense):
|
||||||||
Interest
income
|
.4 | - | ||||||
Interest
expense
|
(10.6 | ) | (9.7 | ) | ||||
Loss
before income taxes
|
(.5 | ) | (36.0 | ) | ||||
Income
tax benefit
|
(.1 | ) | (9.4 | ) | ||||
Net
loss
|
$ | (.4 | ) | $ | (26.6 | ) | ||
Net
loss per basic and diluted share
|
$ | (.01 | ) | $ | (.54 | ) | ||
Cash
dividend per share
|
$ | .25 | $ | - | ||||
Basic
and diluted weighted-average shares used in the calculation of net income
(loss) per share
|
49.0 | 49.0 |
See
accompanying Notes to Condensed Consolidated Financial
Statements.
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME
(LOSS)
Three
months ended March 31, 2009
(In
millions)
Additional
|
Accumulated
other
|
Total
|
||||||||||||||||||||||
Common
stock
|
paid-in
capital
|
Retained
deficit
|
comprehensive
loss
|
stockholders'
equity
|
Comprehensive
income(loss)
|
|||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||
Balance
at December 31, 2008
|
$ | .5 | $ | 1,061.8 | $ | (567.9 | ) | $ | (176.5 | ) | $ | 317.9 | ||||||||||||
Net
loss
|
- | - | (26.6 | ) | - | (26.6 | ) | $ | (26.6 | ) | ||||||||||||||
Other
comprehensive income, net
|
- | - | - | 3.1 | 3.1 | 3.1 | ||||||||||||||||||
Balance
at March 31, 2009
|
$ | .5 | $ | 1,061.8 | $ | (594.5 | ) | $ | (173.4 | ) | $ | 294.4 | ||||||||||||
Comprehensive
loss
|
$ | (23.5 | ) | |||||||||||||||||||||
See
accompanying Notes to Condensed Consolidated Financial
Statements.
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
millions)
Three
months ended
March
31,
|
||||||||
2008
|
2009
|
|||||||
(Unaudited)
|
||||||||
Cash
flows from operating activities:
|
||||||||
Net
income (loss)
|
$ | (.4 | ) | $ | (26.6 | ) | ||
Depreciation
and amortization
|
13.0 | 11.0 | ||||||
Deferred
income taxes
|
.1 | (14.6 | ) | |||||
Benefit
plan expense greater (less) than cash funding:
|
||||||||
Defined
benefit pension plans
|
(2.1 | ) | (1.2 | ) | ||||
Other
postretirement benefits
|
.1 | - | ||||||
Distributions
from (contribution to) TiO2
manufacturing
joint
venture, net
|
1.4 | (1.8 | ) | |||||
Other,
net
|
.8 | (.1 | ) | |||||
Change
in assets and liabilities:
|
||||||||
Accounts
and other receivables
|
(37.7 | ) | (16.0 | ) | ||||
Inventories
|
(3.8 | ) | 79.8 | |||||
Prepaid
expenses
|
(.2 | ) | (2.1 | ) | ||||
Accounts
payable and accrued liabilities
|
.8 | (45.3 | ) | |||||
Income
taxes
|
(4.0 | ) | 3.4 | |||||
Accounts
with affiliates
|
2.4 | (9.7 | ) | |||||
Other,
net
|
.5 | 5.7 | ||||||
Net
cash used in operating activities
|
(29.1 | ) | (17.5 | ) | ||||
Cash
flows from investing activities:
|
||||||||
Capital
expenditures
|
(16.8 | ) | (11.4 | ) | ||||
Change
in restricted cash equivalents
|
.7 | .6 | ||||||
Net
cash used in investing activities
|
(16.1 | ) | (10.8 | ) | ||||
Cash
flows from financing activities:
|
||||||||
Indebtedness:
|
||||||||
Borrowings
|
103.8 | 94.4 | ||||||
Principal
payments
|
(93.5 | ) | (51.5 | ) | ||||
Dividends
paid
|
(12.2 | ) | - | |||||
Net
cash provided by (used in) financing activities
|
(1.9 | ) | 42.9 | |||||
Cash
and cash equivalents - net change from:
|
||||||||
Operating,
investing and financing activities
|
(47.1 | ) | 14.6 | |||||
Currency
translation
|
1.1 | (.6 | ) | |||||
Balance
at beginning of period
|
72.2 | 13.6 | ||||||
Balance
at end of period
|
$ | 26.2 | $ | 27.6 | ||||
Supplemental
disclosures:
|
||||||||
Cash
paid for:
|
||||||||
Interest
|
$ | 1.0 | $ | .7 | ||||
Income
taxes
|
1.0 | .2 | ||||||
Accrual
for capital expenditures
|
3.7 | 1.3 |
See
accompanying Notes to Condensed Consolidated Financial
Statements.
KRONOS
WORLDWIDE, INC. AND SUBSIDIARIES
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March
31, 2009
(Unaudited)
Note
1 - Organization and basis of presentation:
Organization – We
are a majority-owned subsidiary of Valhi, Inc. (NYSE: VHI). At March
31, 2009, Valhi held approximately 59% of our outstanding common stock and NL
Industries, Inc. (NYSE: NL) held an additional 36% of our common
stock. Valhi owns approximately 83% of NL's outstanding common stock.
Approximately 94% of Valhi's outstanding common stock is held by subsidiaries of
Contran Corporation. Substantially all of Contran's outstanding
voting stock is held by trusts established for the benefit of certain children
and grandchildren of Harold C. Simmons (for which Mr. Simmons is sole trustee),
or is held directly by Mr. Simmons or other persons or related companies to Mr.
Simmons. Consequently, Mr. Simmons may be deemed to control each of
these companies.
Basis of presentation – The unaudited Condensed
Consolidated Financial Statements contained in this Quarterly Report have been
prepared on the same basis as the audited Consolidated Financial Statements in
our Annual Report on Form 10-K for the year ended December 31, 2008 that we
filed with the Securities and Exchange Commission (“SEC”) on March 11, 2009 (the
“2008 Annual Report”). In our opinion, we have made all necessary
adjustments (which include only normal recurring adjustments) in order to state
fairly, in all material respects, our consolidated financial position, results
of operations and cash flows as of the dates and for the periods
presented. We have condensed the Consolidated Balance Sheet and
Statement of Stockholders’ Equity and Comprehensive Income (Loss) at December
31, 2008 contained in this Quarterly Report as compared to our audited
Consolidated Financial Statements at that date, and we have omitted certain
information and footnote disclosures (including those related to the
Consolidated Balance Sheet at December 31, 2008) normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”). Our results of operations
for the interim period ended March 31, 2009 may not be indicative of our
operating results for the full year. The Condensed Consolidated
Financial Statements contained in this Quarterly Report should be read in
conjunction with our 2008 Consolidated Financial Statements contained in our
2008 Annual Report.
Unless otherwise indicated, references
in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its
subsidiaries (NYSE: KRO) taken as a whole.
Note
2 – Accounts and other receivables:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Trade
receivables
|
$ | 155.6 | $ | 172.1 | ||||
Recoverable
VAT and other receivables
|
22.2 | 17.6 | ||||||
Refundable
income taxes
|
1.2 | - | ||||||
Receivable
from affiliates:
|
||||||||
Income
taxes, net - Valhi
|
1.2 | - | ||||||
Other
|
.2 | - | ||||||
Allowance
for doubtful accounts
|
(1.8 | ) | (2.2 | ) | ||||
Total
|
$ | 178.6 | $ | 187.5 |
Note
3 - Inventories:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Raw
materials
|
$ | 67.1 | $ | 48.1 | ||||
Work
in process
|
19.8 | 18.2 | ||||||
Finished
products
|
243.0 | 172.2 | ||||||
Supplies
|
55.2 | 56.1 | ||||||
Total
|
$ | 385.1 | $ | 294.6 |
Note
4 - Other noncurrent assets:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Deferred
financing costs, net
|
$ | 7.1 | $ | 6.4 | ||||
Restricted
marketable debt securities
|
3.5 | 3.7 | ||||||
Other
|
1.1 | 1.1 | ||||||
Total
|
$ | 11.7 | $ | 11.2 |
Our marketable debt securities are
carried at fair value using quoted market prices, Level 1 inputs as defined by
Statement of Financial Accounting Standards (“SFAS”) No. 157, Fair Value
Measurements. See Notes 11 and 12.
Note
5 – Accounts payable and accrued liabilities:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Accounts
payable
|
$ | 113.5 | $ | 59.0 | ||||
Employee
benefits
|
23.4 | 22.3 | ||||||
Accrued
sales discounts and rebates
|
14.9 | 10.0 | ||||||
Accrued
interest
|
7.8 | 16.8 | ||||||
Payable
to affiliates:
|
||||||||
Louisiana
Pigment Company, L.P.
|
14.3 | 7.8 | ||||||
Income
taxes, net - Valhi
|
.4 | 1.0 | ||||||
Other
|
21.0 | 19.7 | ||||||
Total
|
$ | 195.3 | $ | 136.6 |
Note
6 - Long-term debt:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Kronos
International, Inc. - 6.5% Senior Secured Notes
|
$ | 560.0 | $ | 538.2 | ||||
Revolving
credit facilities:
|
||||||||
European
credit facility
|
42.2 | 68.9 | ||||||
U.S.
bank credit facility
|
13.7 | 30.2 | ||||||
Note
payable to affiliate
|
19.2 | 16.6 | ||||||
Other
|
3.4 | 3.4 | ||||||
Total
debt
|
638.5 | 657.3 | ||||||
Less
current maturities
|
.8 | 69.7 | ||||||
Total
long-term debt
|
$ | 637.7 | $ | 587.6 |
Revolving credit facilities –
During the first three months of 2009, we borrowed a net euro 21.0 million
($26.7 million) under our European credit facility and a net $16.5 million under
our U.S. credit facility. The average interest rate on these
outstanding borrowings at March 31, 2009 was 3.88% and 3.25%,
respectively.
Our Canadian subsidiary’s revolving
credit facility had a maturity date of January 15, 2009. Prior to
maturity we temporarily extended the borrowing terms of this agreement on a
month-to-month basis and we are in the process of renegotiating this
facility. We expect a new agreement to be in place in the second
quarter 2009. At March 31, 2009, no amounts were outstanding under
the facility.
Note payable to affiliate –
During the first three months of 2009, we repaid a net $2.6 million under our
revolving note with NL. At March 31, 2009 the interest rate was 1.75%
on our borrowings from NL. Our borrowings under this revolving note
were classified as a noncurrent liability at March 31, 2009 because we have the
ability and intent to refinance the outstanding amount payable by using
borrowing availability under our U.S. revolving credit facility that matures in
September 2011.
Restrictions and Other. Under the cross-default
provisions of the 6.5% Notes, the 6.5% Notes may be accelerated prior to their
stated maturity if our European subsidiaries default under any other
indebtedness in excess of $20 million due to a failure to pay the other
indebtedness at its due date (including any due date that arises prior to the
stated maturity as a result of a default under the other
indebtedness). Under the cross-default provisions of the European
revolving credit facility, any outstanding borrowings under the facility may be
accelerated prior to their stated maturity if the borrowers or their parent
company default under any other indebtedness in excess of euro 5 million due to
a failure to pay the other indebtedness at its due date (including any due date
that arises prior to the stated maturity as a result of a default under the
other indebtedness). Under the cross-default provisions of the U.S.
revolving credit facility, any outstanding borrowing under the facility may be
accelerated prior to their stated maturity in the event of the bankruptcy of
Kronos. The Canadian revolving credit facility contains no
cross-default provisions. The European, U.S. and Canadian revolving credit
facilities each contain provisions that allow the lender to accelerate the
maturity of the applicable facility in the event of a change of control, as
defined in the respective agreement, of the applicable borrower. In
the event any of these cross-default or change-of-control provisions become
applicable, and the indebtedness is accelerated, we would be required to repay
the indebtedness prior to their stated maturity.
Certain
of the credit facilities described above require the respective borrower to
maintain minimum levels of equity, require the maintenance of certain financial
ratios, limit dividends and additional indebtedness and contain other provisions
and restrictive covenants customary in lending transactions of this
type. On March 20, 2009, the lenders associated with our European
credit facility waived compliance with the required financial ratio of the
borrowers’ net secured debt to earnings before income taxes, interest and
depreciation, as defined in the amended revolving Credit Facility, for the
12-month period ending March 31, 2009. Among other things, such
waiver moved the next required financial ratio measurement period to the
12-month period ending April 30, 2009. On April 30, 2009, all of the
lenders waived compliance with the required financial ratio for the 12-month
period ending April 30, 2009. Among other things, this waiver moved
the next required financial ratio measurement period to the 12-month period
ending June 15, 2009. We did not pay any fee to the lenders to obtain
either waiver. Absent receiving the waiver we would have been in
violation of this financial ratio. In addition, we believe it is
probable that we will not be able to comply with this financial ratio for the
next 12-month period, as a result we have classified the outstanding balance of
the European credit facility as a current liability at March 31,
2009. In 2009, we have reduced our production levels in response to
the current economic environment, which has favorably impacted our liquidity and
cash flows by reducing our inventory levels. We expect to continue to
maintain reduced levels of production for the remainder of
2009. However, the reduced capacity utilization levels will
negatively impact our 2009 results of operations due to the resulting unabsorbed
fixed production costs that will be charged to expense as
incurred. As a result, we may not be able to maintain the required
financial ratio throughout 2009.
We have
begun discussions with the lenders to amend the terms of the existing European
credit facility to eliminate the requirement to maintain this financial ratio
until at least March 31, 2010. While we believe it is possible we can
obtain such an amendment to eliminate this financial ratio through at least
March 31, 2010, there is no assurance that such amendment will be obtained, or
if obtained that the requirement to maintain the financial ratio will be
eliminated (or waived, in the event the lenders would only agree to a waiver and
not an amendment to eliminate the covenant itself) through at least March 31,
2010. Any such amendment or waiver which we might obtain could
increase our future borrowing costs, either from a requirement that we pay a
higher rate of interest on outstanding borrowings and/or pay a fee to the
lenders as part of agreeing to such amendment or waiver.
In the
event we are not successful in obtaining the amendment or waiver of the existing
European credit facility to eliminate the requirement to maintain the financial
ratio, we would seek to refinance such facility with a new group of lenders with
terms that would not include such financial covenant or, if required, use our
existing liquidity resources (which could include funds provided by our
affiliates). While there is no assurance that we would be able
to refinance the existing European credit facility with a new group of lenders,
we believe these other sources of liquidity available to us should allow us to
refinance the existing European credit facility. If required, we
believe by undertaking one or more of these steps we would be successful in
maintaining sufficient liquidity to meet our future obligations including
operations, capital expenditures and debt service for the next 12
months.
The terms of the indenture governing
the Senior Secured Notes limits the ability of Kronos International, Inc.
(“KII”), our wholly owned subsidiary that issued the notes, to pay dividends and
make other restricted payments. At March 31, 2009, the maximum amount
of dividends and other restricted payments that KII could make (the “Restricted
Payment Basket”) was approximately $27.3 million. However, the
indenture currently prohibits KII from utilizing the Restricted Payment Basket
because we have not met a specified financial ratio contained in the indenture;
such prohibition will continue until such time as we meet the specified
financial ratio.
Note
7 - Income taxes:
Three
months ended
March 31,
|
||||||||
2008
|
2009
|
|||||||
(In
millions)
|
||||||||
Expected
tax expense (benefit), at U.S. Federal statutory income tax rate of
35%
|
$ | (.2 | ) | $ | (12.6 | ) | ||
Non-U.S.
tax rates
|
- | 1.3 | ||||||
Nondeductible
expenses
|
- | 2.1 | ||||||
U.S.
state income taxes, net
|
- | 0.9 | ||||||
Change
in reserve for uncertain tax positions
|
.1 | (0.2 | ) | |||||
Nontaxable
income
|
- | (1.0 | ) | |||||
Other,
net
|
- | 0.1 | ||||||
Total
|
$ | (.1 | ) | $ | (9.4 | ) |
Certain
of our non-U.S. tax returns are being examined and tax authorities may propose
tax deficiencies including interest and penalties. We cannot guarantee
that these tax matters will be resolved in our favor due to the inherent
uncertainties involved in settlement initiatives and court and tax
proceedings. We believe we have adequate accruals for additional taxes and
related interest expense which could ultimately result from tax
examinations. We believe the ultimate disposition of tax examinations
should not have a material adverse effect on our consolidated financial
position, results of operations or liquidity. We do not currently believe
that our unrecognized tax benefits will change significantly within the next
twelve months.
Note
8 – Employee benefit plans:
Defined benefit plans - The
components of net periodic defined benefit pension cost are presented in the
table below.
Three
months ended
|
||||||||
March 31,
|
||||||||
2008
|
2009
|
|||||||
(In
millions)
|
||||||||
Service
cost
|
$ | 1.7 | $ | 1.8 | ||||
Interest
cost
|
6.1 | 5.4 | ||||||
Expected
return on plan assets
|
(5.1 | ) | (3.9 | ) | ||||
Amortization
of prior service cost
|
.2 | .3 | ||||||
Amortization
of net transition obligations
|
.1 | .1 | ||||||
Recognized
actuarial losses
|
1.2 | 1.3 | ||||||
Total
|
$ | 4.2 | $ | 5.0 |
Postretirement benefits - The
components of net periodic postretirement benefits other than pension (“OPEB”)
cost are presented in the table below.
Three
months ended
March 31,
|
||||||||
2008
|
2009
|
|||||||
(In
millions)
|
||||||||
Service
cost
|
$ | .1 | $ | .1 | ||||
Interest
cost
|
.2 | .1 | ||||||
Amortization
of prior service credit
|
(.1 | ) | (.1 | ) | ||||
Total
|
$ | .2 | $ | .1 |
Contributions – We expect our
2009 contributions for our pension and other postretirement plans to be
consistent with the amounts we disclosed in our 2008 Annual Report.
Note
9 – Other noncurrent liabilities:
December
31,
2008
|
March
31,
2009
|
|||||||
(In
millions)
|
||||||||
Reserve
for uncertain tax positions
|
$ | 13.1 | $ | 12.8 | ||||
Employee
benefits
|
8.9 | 8.5 | ||||||
Insurance
claims and expenses
|
1.8 | 2.2 | ||||||
Other
|
5.0 | 4.9 | ||||||
Total
|
$ | 28.8 | $ | 28.4 |
Note
10 – Commitments and contingencies:
Litigation matters – From
time-to-time, we are involved in various environmental, contractual, product
liability, patent (or intellectual property), employment and other claims and
disputes incidental to our operations. In certain cases, we have
insurance coverage for these items. We currently believe the
disposition of all claims and disputes, individually or in the aggregate, should
not have a material adverse effect on our consolidated financial position,
results of operations or liquidity beyond the accruals we have already provided
for.
Please
refer to our 2008 Annual Report for a discussion of certain other legal
proceedings to which we are a party.
Note
11 – Financial Instruments:
The
following table summarizes the valuation of our short-term investments and
financial instruments recorded on a fair value basis in accordance with SFAS
No. 157 categories as of March 31, 2009:
Fair Value Measurements at March 31,
2009
|
||||||||||||||||
Total
|
Quoted
Prices in Active Markets (Level
1)
|
Significant
Other Observable Inputs (Level
2)
|
Significant
Unobservable Inputs (Level
3)
|
|||||||||||||
(in
millions)
|
||||||||||||||||
Marketable
securities
|
$ | 3.7 | $ | 3.7 | $ | - | $ | - | ||||||||
Currency
forward contracts
|
2.1 | 2.1 | - | - | ||||||||||||
Certain
of our sales generated by our non-U.S. operations are denominated in U.S.
dollars. We periodically use currency forward contracts to manage a very
nominal portion of currency exchange rate risk associated with trade receivables
denominated in a currency other than the holder's functional currency or similar
exchange rate risk associated with future sales. We have not entered into
these contracts for trading or speculative purposes in the past, nor do we
currently anticipate entering into such contracts for trading or speculative
purposes in the future. At March 31, 2009, we had currency forward
contracts to exchange:
·
|
an
aggregate of $22.5 million for an equivalent value of Canadian dollars at
exchange rates ranging from Cdn. $1.25 to Cdn. $1.26 per U.S.
dollar. These contracts with U.S. Bank mature from April 2009
through December 2009 at a rate of $2.5 million per month. At March
31, 2009, the actual exchange rate was Cdn. $1.25 per U.S.
dollar.
|
·
|
an
aggregate $56.5 million for an equivalent value of Norwegian kroner at
exchange rates ranging from kroner 6.51 to kroner 7.18 per U.S.
dollar. These contracts with DnB Nor Bank ASA mature from April 2009
through March 2010 at a rate of $.5 million to $4.75 million per
month. At March 31, 2009, the actual exchange rate was kroner
6.51 per U.S. dollar.
|
·
|
an
aggregate euro 16.4 million for an equivalent value of Norwegian kroner at
exchange rates ranging from kroner 8.68 to kroner 9.23 per euro.
These contracts with DnB Nor Bank ASA mature from April 2009 through March
2010 at a rate of euro .5 million to euro 1.7 million per
month. At March 31, 2009, the actual exchange rate was kroner
8.89 per euro.
|
The
estimated fair value of such currency forward contracts at March 31, 2009 was a
$2.1 million net asset, which is the net result of $2.7 million recognized as
part of Prepaid Expenses and Other and $.6 million recognized as part of
Accounts Payable and Accrued Liabilities in our Condensed Consolidated Balance
Sheet. There is also a corresponding $2.1 million currency
transaction gain in our Condensed Consolidated Statement of
Operations. To the extent we held such contracts during 2008, we did
not use hedge accounting for any of such contracts, and we are not currently
using hedge accounting for our existing contracts.
Note
12 – Recent accounting pronouncements:
Fair Value
Measurements. In
September 2006, the Financial Accounting Standards Board (“FASB”) issued SFAS
No. 157, Fair Value
Measurements, which became effective for us on January 1, 2008.
SFAS No. 157 generally provides a consistent, single fair value definition and
measurement techniques for GAAP pronouncements. SFAS No. 157 also
establishes a fair value hierarchy for different measurement techniques based on
the objective nature of the inputs in various valuation methods. In
February 2008, the FASB issued FASB Staff Position (“FSP”) No. FAS 157-2, Effective Date of FASB Statement No.
157 which delayed the provisions of SFAS No. 157 until January 1, 2009
for all nonfinancial assets and nonfinancial liabilities, except those that are
recognized or disclosed at fair value in the financial statements on a recurring
basis (at least annually). All of our fair value measurements are in
compliance with SFAS No. 157 at March 31, 2009. The adoption of this standard
did not have a material effect on our Consolidated Financial
Statements.
Fair Value
Disclosure. In April 2009,
the FASB issued FSP FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value
of Financial Instruments. This FSP will require us to disclose
the fair value of all financial instruments for which it is practicable to
estimate the value, whether recognized or not in the statement of financial
position, as required by SFAS No. 107, Disclosures about Fair Value of
Financial Instruments at interim as well as annual
periods. Prior to the adoption of the FSP, we are only required
to disclose this information annually. This FSP will become effective
for us in the second quarter of 2009. See Note 11 for disclosures
related to financial instruments recorded at fair value. The adoption
of the FSP will not affect our Condensed Consolidated Financial
Statements.
Derivative
Disclosures. In
March 2008 the FASB issued SFAS No. 161, Disclosures about Derivative
Instruments and Hedging Activities, an Amendment of FASB Statement No. 133,
which became effective for us in the first quarter of 2009. SFAS
No. 161 changes the disclosure requirements for derivative instruments and
hedging activities to provide enhanced disclosures about how and why we use
derivative instruments, how derivative instruments and related hedged items are
accounted for under SFAS No. 133 and how derivative instruments and related
hedged items affect our financial position and performance and cash flows.
We periodically use currency forward contracts to manage a portion of our
currency exchange rate market risk associated with trade receivables or future
sales. Because our prior disclosures regarding these forward contracts
substantially met all of the applicable disclosure requirements of the new
standard, its effectiveness did not have a significant effect on our
Consolidated Financial Statements.
Benefit Plan
Asset Disclosures. During
the fourth quarter of 2008, the FASB issued FSP SFAS 132 (R)-1, Employers’ Disclosures about
Postretirement Benefit Plan Assets, which amends SFAS No. 87, 88 and 106
to require expanded disclosures about employers’ pension plan
assets. FSP 132 (R)-1 will become effective for us beginning with our
2009 annual report, and we will provide the expanded disclosures about our
pension plan assets at that time.
Other-Than-Temporary-Impairments. In
April 2009, the FASB issued FSP FAS 115-2 and FAS 124-2, Recognition and Presentation of
Other-Than-Temporary-Impairments. The FSP amends existing
guidance for the recognition and measurement of other-than-temporary impairments
for debt securities classified as available-for-sale and held-to-maturity, and
expands the disclosure requirements for interim and annual periods for
available-for-sale and held-to-maturity debt and equity securities, including
information about investments in an unrealized loss position for which an
other-than-temporary impairment has or has not been recognized. This
FSP will become effective for us in the second quarter of 2009 and is not
expected to have a material effect on our Condensed Consolidated Financial
Statements.
ITEM
2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
RESULTS
OF OPERATIONS:
Business
and results of operations overview
We are a leading global producer and
marketer of value-added titanium dioxide pigments (“TiO2”). TiO2 is used
for a variety of manufacturing applications, including plastics, paints, paper
and other industrial products. For the three months ended March 31,
2009, approximately one-half of our sales volumes were into European
markets. We believe we are the second largest producer of TiO2 in Europe
with an estimated 19% share of European TiO2 sales
volumes. In addition, we also have an estimated 16% share of North
American TiO2 sales
volumes. Our production facilities are located throughout Europe and
North America.
We reported a net loss of $26.6
million, or $.54 per diluted share, in the first quarter of 2009 as compared to
a net loss of $.4 million, or $.01 per diluted share, in the first quarter of
2008. Our larger net loss for the first quarter 2009 is primarily due
to lower income (loss) from operations resulting principally from lower sales
and production volumes.
Forward-looking
information
This report contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Statements in this Quarterly Report on Form 10-Q that are not
historical in nature are forward-looking in nature about our future that are not
statements of historical fact. Statements in this report including,
but not limited to, statements found in Item 2 - "Management’s Discussion and
Analysis of Financial Condition and Results of Operations," are forward-looking
statements that represent our beliefs and assumptions based on currently
available information. In some cases you can identify these
forward-looking statements by the use of words such as "believes," "intends,"
"may," "should," "could," "anticipates," "expected" or comparable terminology,
or by discussions of strategies or trends. Although we believe the
expectations reflected in forward-looking statements are reasonable, we do not
know if these expectations will be correct. Forward-looking
statements by their nature involve substantial risks and uncertainties that
could significantly impact expected results. Actual future results
could differ materially from those predicted. While it is not
possible to identify all factors, we continue to face many risks and
uncertainties. Among the factors that could cause our actual future
results to differ materially from those described herein are the risks and
uncertainties discussed in this Quarterly Report and those described from time
to time in our other filings with the SEC including, but not limited to, the
following:
·
|
Future
supply and demand for our products
|
·
|
The
extent of the dependence of certain of our businesses on certain market
sectors
|
·
|
The
cyclicality of our businesses
|
·
|
Customer
inventory levels (such as the extent to which our customers may, from time
to time, accelerate purchases of TiO2 in
advance of anticipated price increases or defer purchases of TiO2 in
advance of anticipated price
decreases)
|
·
|
Changes
in raw material and other operating costs (such as energy
costs)
|
·
|
General
global economic and political conditions (such as changes in the level of
gross domestic product in various regions of the world and the impact of
such changes on demand for TiO2)
|
·
|
Competitive
products and substitute products
|
·
|
Customer
and competitor strategies
|
·
|
Potential
consolidation or solvency of our
competitors
|
·
|
The
impact of pricing and production
decisions
|
·
|
Competitive
technology positions
|
·
|
Possible
disruption of our business or increases in the cost of doing business
resulting from terrorist activities or global
conflicts
|
·
|
The
introduction of trade barriers
|
·
|
Fluctuations
in currency exchange rates (such as changes in the exchange rate between
the U.S. dollar and each of the euro, the Norwegian krone and the Canadian
dollar)
|
·
|
Operating
interruptions (including, but not limited to, labor disputes, leaks,
natural disasters, fires, explosions, unscheduled or unplanned downtime
and transportation interruptions)
|
·
|
The
timing and amounts of insurance
recoveries
|
·
|
Our
ability to renew or refinance credit
facilities
|
·
|
Our
ability to maintain sufficient
liquidity
|
·
|
The
ultimate outcome of income tax audits, tax settlement initiatives or other
tax matters
|
·
|
The
ultimate ability to utilize income tax attributes, the benefits of which
have been recognized under the more-likely-than-not recognition
criteria
|
·
|
Environmental
matters (such as those requiring compliance with emission and discharge
standards for existing and new
facilities)
|
·
|
Government
laws and regulations and possible changes
therein
|
·
|
The
ultimate resolution of pending
litigation
|
·
|
Possible
future litigation
|
Should
one or more of these risks materialize (or the consequences of such a
development worsen), or should the underlying assumptions prove incorrect,
actual results could differ materially from those forecasted or
expected. We disclaim any intention or obligation to update or revise
any forward-looking statement whether as a result of changes in information,
future events or otherwise.
Results
of operations
We
consider TiO2 to be a
“quality of life” product, with demand affected by gross domestic product (or
“GDP”) and overall economic conditions in our markets located in various regions
of the world. Over the long-term, we expect that demand for TiO2 will grow
by 2% to 3% per year, consistent with our expectations for the long-term growth
in GDP. However, even if we and our competitors maintain consistent
shares of the worldwide market, demand for TiO2 in any
interim or annual period may not change in the same proportion as the change in
GDP, in part due to relative changes in the TiO2 inventory
levels of our customers. We believe that our customers’ inventory
levels are partly influenced by their expectation for future changes in market
TiO2
selling prices. The majority of our TiO2 grades and
substantially all of our production are considered commodity pigment products,
we compete for sales primarily on the basis of price.
The
factors having the most impact on our reported operating results
are:
·
|
TiO2
selling prices,
|
·
|
Currency
exchange rates (particularly the exchange rate for the U.S. dollar
relative to the euro, Norwegian krone and the Canadian
dollar),
|
·
|
Our
TiO2
sales and production volumes and
|
·
|
Manufacturing
costs, particularly raw materials, maintenance and energy-related
expenses.
|
Our key
performance indicators are our TiO2 average
selling prices, and our level of TiO2 sales and
production volumes. TiO2 selling
prices generally follow industry trends and prices will increase or decrease
generally as a result of competitive market pressures.
Quarter
ended March 31, 2008 compared to the
Quarter
ended March 31, 2009 -
Three
months ended
March 31,
|
||||||||||||||||
2008
|
2009
|
|||||||||||||||
(Dollars
in millions)
|
||||||||||||||||
Net
sales
|
$ | 332.5 | 100 | % | $ | 248.0 | 100 | % | ||||||||
Cost
of sales
|
275.4 | 83 | 243.9 | 98 | ||||||||||||
Gross
margin
|
57.1 | 17 | 4.1 | 2 | ||||||||||||
Other
operating income and expenses, net
|
47.4 | 14 | 30.4 | 12 | ||||||||||||
Income
(loss) from operations
|
$ | 9.7 | 3 | % | $ | (26.3 | ) | (10 | )% | |||||||
%
|
||||||||||||||||
Change
|
||||||||||||||||
TiO2
operating statistics:
|
||||||||||||||||
Sales
volumes*
|
127 | 97 | (24 | )% | ||||||||||||
Production
volumes*
|
132 | 64 | (52 | )% | ||||||||||||
Percent
change in net sales:
|
||||||||||||||||
TiO2
product pricing
|
5 | % | ||||||||||||||
TiO2
sales volumes
|
(24 | ) | ||||||||||||||
TiO2
product mix
|
(2 | ) | ||||||||||||||
Changes
in currency exchange rates
|
(4 | ) | ||||||||||||||
Total
|
(25 | )% |
*
Thousands of metric tons
Net sales – Net sales
decreased 25% or $84.5 million compared to the first quarter of 2008 primarily
due to a 24% decrease in sales volumes. A 5% increase in average
TiO2
selling prices over 2008 was mostly offset by the negative impact of currency
exchange rates. We estimate the unfavorable effect of changes in
currency exchange rates decreased our net sales by approximately $13 million, or
4%, as compared to the same period in 2008. We expect average selling
prices in the second quarter of 2009 to be lower than the average selling prices
in the first quarter of 2009.
Sales
volumes in the first quarter of 2009 were 24% lower compared to 2008 due to the
impact of lower demand in our markets resulting from the current economic
conditions. We expect demand will continue to remain below 2008
levels for the remainder of the year.
Cost of sales
- Cost of sales decreased
$31.5 million or 11% in the first quarter of 2009 compared to 2008 primarily due
to the impact of a 24% decrease in sales volumes, a 52% decrease in
TiO2 production volumes, a decrease in
maintenance costs of $8.2 million and currency fluctuations (primarily the
euro). Cost of sales as a percentage of net sales increased to 98% in
the first quarter of 2009 compared to 83% in the first quarter of 2008 due to
the unfavorable effects of the significant amount of unabsorbed fixed production
costs resulting from reduced production volumes. TiO2 production volumes decreased due to
temporary plant curtailments during the first quarter of 2009 that resulted in
approximately $50 million of unabsorbed fixed production costs which were
charged directly to cost of sales in the first quarter of 2009.
Income (loss) from operations –
Income from operations declined by $36 million from operating income of
$9.7 million in the first quarter of 2008 to an operating loss of $26.3 million
in the first quarter of 2009. Income (loss) from operations as
a percentage of net sales declined to (10)% in the first quarter of 2009 from 3%
in the same period for 2008. This decrease is driven by the decline
in gross margin, which fell to 2% for the first quarter of 2009 compared to 17%
for the first quarter of 2008. Our gross margin has decreased
primarily because of lower sales volumes and higher manufacturing costs
resulting from lower production volumes. Changes in currency rates
have positively affected our gross margin and income (loss) from
operations. We estimate the positive effect of changes in currency
exchange rates increased income from operations by approximately $28 million in
the first quarter of 2009 as compared to the same period in 2008.
Interest expense – Interest
expense decreased $.9 million from $10.6 million in the first quarter of 2008 to
$9.7 million in the first quarter of 2009 primarily due to changes in currency
exchange rates. Excluding the effect of currency exchange rates, we
expect interest expense will be higher in 2009 as compared to 2008 due to
anticipated increased average borrowings under our revolving credit
facilities.
We have a
significant amount of indebtedness denominated in the euro, primarily the 6.5%
Senior Secured Notes. The interest expense we recognize will vary
with fluctuations in the euro exchange rate.
Income tax benefit – Our
income tax benefit was $9.4 million in the first quarter of 2009 compared to an
income benefit of $.1 million in the same period last year. See Note 7 to
our Condensed Consolidated Financial Statements for a tabular reconciliation of
our statutory income tax benefit to our actual tax benefit.
We have
substantial net operating loss carryforwards in Germany (the equivalent of $817
million for German corporate purposes and $229 million for German trade tax
purposes at December 31, 2008). At March 31, 2009, we have concluded that
no deferred income tax asset valuation allowance is required to be recognized
with respect to such carryforwards, principally because (i) such carryforwards
have an indefinite carryforward period, (ii) we have utilized a portion of such
carryforwards during the most recent three-year period and (iii) we currently
expect to utilize the remainder of such carryforwards over the long
term. However, prior to the complete utilization of these
carryforwards, particularly if the current economic downturn continues and
we generate operating losses in our German operations for an extended
period of time, it is possible we might conclude the benefit of the
carryforwards would no longer meet the more-likely-than-not recognition
criteria, at which point we would be required to recognize a valuation allowance
against some or all of the then-remaining tax benefit associated with the
carryforwards.
Currency
exchange
We
have substantial
operations and assets located outside the United States (primarily in Germany,
Belgium, Norway and Canada). The majority of our non-U.S. operations’
sales are denominated in currencies other than the U.S. dollar, principally the
euro, other major European currencies and the Canadian dollar. A
portion of our sales generated from our non-U.S. operations are denominated in
the U.S. dollar. Certain raw materials used worldwide, primarily
titanium-containing feedstocks, are purchased in U.S. dollars, while labor and
other production costs are purchased primarily in local
currencies. Consequently, the translated U.S. dollar value of our
non-U.S. sales and operating results are subject to currency exchange rate
fluctuations which may favorably or unfavorably impact reported earnings and may
affect the comparability of period-to-period operating
results. Overall, we estimate that fluctuations in currency exchange
rates had the following effects on our sales and income from operations for the
first quarter of 2009 as compared to the first quarter of 2008.
Three
months ended
March
31, 2009 vs. 2008
|
||||
Increase
(decrease) in millions
|
||||
Impact
on:
|
||||
Net
sales
|
$ | (13 | ) | |
Income
from operations
|
28 |
Outlook
We
currently expect income from operations will continue to be lower in 2009 as
compared to 2008 primarily due to higher production costs resulting in part from
significantly reduced production volumes and the resulting unabsorbed fixed
production costs. We currently expect to report a net loss in 2009 as
compared to reporting net income in 2008 due to lower expected income from
operations in 2009.
In
response to the worldwide economic slowdown and weak consumer confidence, we are
significantly reducing our production volumes in 2009 in order to reduce our
finished goods inventory and improve our liquidity. Overall industry
pigment demand is expected to be lower in 2009 as compared to 2008 as a result
of worldwide economic conditions. While we currently expect our sales
volumes in 2009 will be lower as compared to 2008, we expect to gain market
share following anticipated reductions in industry capacity due to competitors’
permanent plant shutdowns. We believe average selling prices in 2009
will decline from year-end 2008 levels during the first half of the year but we
anticipate prices will rise during the second half of 2009, which should result
in slightly higher average worldwide TiO2 selling
prices for the year. To mitigate the negative impact of our
significantly reduced production volumes, we are reducing our operating costs
where possible, including maintenance expenditures and personnel
costs.
Our
expectations as to the future of the TiO2 industry
are based upon a number of factors beyond our control, including worldwide
growth of gross domestic product, competition in the marketplace, solvency and
continued operation of competitors, unexpected or earlier than expected capacity
additions or reductions and technological advances. If actual
developments differ from our expectations, our results of operations could be
unfavorably affected.
We
believe that our annual attainable production capacity for 2009 is approximately
532,000 metric tons. We expect our production volumes in 2009 will be
significantly lower than our attainable capacity. We currently expect
we will operate at 70% to 80% of our attainable production capacity in 2009. Our
expected capacity utilization levels could be adjusted upwards or downwards to
match changes in demand for our product.
LIQUIDITY
AND CAPITAL RESOURCES
Consolidated
cash flows
Operating
activities
Trends in
cash flows as a result of our operating activities (excluding the impact of
significant asset dispositions and relative changes in assets and liabilities)
are generally similar to trends in our earnings.
Our cash used in operating activities
was $17.5 million in the first three months of 2009 compared to $29.1 million in
the first three months of 2008. This $11.6 million decrease in the
amount of cash used was primarily due to the net effects of the following
items:
·
|
Lower
income from operations in 2009 of $36.0 million
and
|
·
|
Lower
net cash used from relative changes in our inventories, receivables,
payables and accruals of $47.0 million in 2009 primarily due to our
reducing inventory levels, as discussed
below.
|
Changes
in working capital were affected by accounts receivable and inventory
changes. Our average days sales outstanding (“DSO”) increased from 64
days at December 31, 2008 to 68 days at March 31, 2009 due to the timing of
collection on higher accounts receivable balances at the end of
March. For comparative purposes, our average DSO increased from 63
days at December 31, 2007 to 72 days at March 31, 2008. Our average
days sales in inventory (“DSI”) decreased from 113 days at December 31, 2008 to
64 days at March 31, 2009, as our TiO2 sales
volumes exceeded our TiO2 production
volumes in the first three months of 2009. For comparative purposes,
our average DSI increased from 59 days at December 31, 2007 to 64 days at March
31, 2008.
Investing
activities
Our
capital expenditures of $16.8 million and $11.4 million in the three months
ended March 31, 2008 and 2009, respectively, were primarily for improvements and
upgrades to existing facilities. Compared to 2008, we have lowered
our planned capital expenditures in 2009 in response to the current economic
conditions.
Financing
activities
During
the three months ended March 31, 2009, we:
·
|
had
net borrowings of $16.5 million on our U.S. credit
facility;
|
·
|
had
net borrowings of euro 21.0 million ($28.9 million when borrowed/repaid)
on our European credit facility;
and
|
·
|
made
net payments of $2.6 million on our revolving note with our affiliate
NL.
|
In the
three months ended March 31, 2008, we paid a quarterly dividend to stockholders
of $.25 per share for an aggregate dividend $12.2 million. We did not
pay a dividend in the three months ended March 31, 2009.
Outstanding
debt obligations
At March
31, 2009, our consolidated debt was comprised principally of:
·
|
euro
400 million principal amount of our 6.5% Senior Secured Notes ($538.2
million) due in 2013;
|
·
|
euro
51.0 million ($68.9 million) under our European revolving credit facility
which matures in May 2011;
|
·
|
$30.2
million under our U.S. revolving credit facility which matures in
September 2011;
|
·
|
$16.6
million under our revolving note with NL which matures in December 2009;
and
|
·
|
Approximately
$3.4 million of other indebtedness.
|
Under the
cross-default provisions of the 6.5% Notes, the 6.5% Notes may be accelerated
prior to their stated maturity if our European subsidiaries default under any
other indebtedness in excess of $20 million due to a failure to pay the other
indebtedness at its due date (including any due date that arises prior to the
stated maturity as a result of a default under the other
indebtedness). Under the cross-default provisions of the European
revolving credit facility, any outstanding borrowings under the facility may be
accelerated prior to their stated maturity if the borrowers or their parent
company default under any other indebtedness in excess of euro 5 million due to
a failure to pay the other indebtedness at its due date (including any due date
that arises prior to the stated maturity as a result of a default under the
other indebtedness). Under the cross-default provisions of the U.S.
revolving credit facility, any outstanding borrowing under the facility may be
accelerated prior to their stated maturity in the event of the bankruptcy of
Kronos. The Canadian revolving credit facility contains no
cross-default provisions. The European, U.S. and Canadian revolving credit
facilities each contain provisions that allow the lender to accelerate the
maturity of the applicable facility in the event of a change of control, as
defined in the respective agreement, of the applicable borrower. In
the event any of these cross-default or change-of-control provisions become
applicable, and the indebtedness is accelerated, we would be required to repay
the indebtedness prior to their stated maturity.
Certain
of the credit facilities described above require the respective borrower to
maintain minimum levels of equity, require the maintenance of certain financial
ratios, limit dividends and additional indebtedness and contain other provisions
and restrictive covenants customary in lending transaction of this
type. On March 20, 2009, the lenders associated with our European
credit facility waived compliance with the required financial ratio of the
borrowers’ net secured debt to earnings before income taxes, interest and
depreciation, as defined in the amended revolving Credit Facility, for the
12-month period ending March 31, 2009. Among other things, such
waiver moved the next required financial ratio measurement period to the
12-month period ending April 30, 2009. On April 30, 2009, all of the
lenders waived compliance with the required financial ratio for the 12-month
period ending April 30, 2009. Among other things, this waiver moved
the next required financial ratio measurement period to the 12-month period
ending June 15, 2009. We did not pay any fee to the lenders to obtain
either waiver. Absent receiving the waiver we would have been in
violation of the financial ratio. In addition, we believe it is
probable that we will not be able to comply with this financial ratio for the
next 12-month period, as a result we have classified the outstanding balance of
the European credit facility as a current liability at March 31,
2009. In 2009, we have reduced our production levels in response to
the current economic environment, which has favorably impacted our liquidity and
cash flows by reducing our inventory levels. We expect to
continue to maintain reduced levels of production for the remainder of
2009. However, the reduced capacity utilization levels will
negatively impact our 2009 results of operations due to the resulting unabsorbed
fixed production costs that will be charged to expense as
incurred. As a result, we may not be able to maintain the required
financial ratio throughout 2009.
We have
begun discussions with the lenders to amend the terms of the existing European
credit facility to eliminate the requirement to maintain this financial ratio
until at least March 31, 2010. While we believe it is possible we can obtain
such amendment to eliminate this financial ratio through at least March 31,
2010, there is no assurance that such amendment will be obtained, or if obtained
that the requirement to maintain the financial ratio will be eliminated (or
waived, in the event the lenders would only agree to a waiver and not an
amendment to eliminate the covenant itself) through at least March 31,
2010. Any such amendment or waiver which we might obtain could
increase our future borrowing costs, either from a requirement that we pay a
higher rate of interest on outstanding borrowings and/or pay a fee to the
lenders as part of agreeing to such amendment or waiver.
In the
event we are not successful in obtaining the amendment or waiver of the existing
European credit facility to eliminate the requirement to maintain the financial
ratio, we would seek to refinance such facility with a new group of lenders with
terms that would not include such financial covenant or, if required, use our
existing liquidity resources (which could include funds provided by our
affiliates). While there is no assurance that we would be able to
refinance the existing European credit facility with a new group of lenders, we
believe these other sources of liquidity available to us should allow us to
refinance the existing European credit facility. If required, we
believe by undertaking one or more of these steps we would be successful in
maintaining sufficient liquidity to meet our future obligations including
operations, capital expenditures and debt service for the next 12
months.
Our
assets consist primarily of investments in operating subsidiaries, and our
ability to service parent level obligations, including the Senior Secured Notes,
depends in large part upon the distribution of earnings of our subsidiaries,
whether in the form of dividends, advances or payments on account of
intercompany obligations or otherwise. None of our subsidiaries have
guaranteed the Senior Secured Notes, although Kronos International, Inc. (“KII”)
has pledged 65% of the common stock or other ownership interests of certain of
KII’s first-tier operating subsidiaries as collateral for the Senior Secured
Notes. The terms of indenture governing the Senior Secured Notes limits KII’s
ability to pay dividends and make other restricted payments. At March
31, 2009, the maximum amount of dividends and other restricted payments that KII
could make (the “Restricted Payment Basket”) was approximately $27.3
million. However, the indenture currently prohibits KII from
utilizing the Restricted Payment Basket because we have not met a specified
financial ratio contained in this indenture; such prohibition will continue
until such time as we meet the specified financial ratio.
Future
cash requirements
Liquidity
Our
primary source of liquidity on an ongoing basis is cash flows from operating
activities. From time-to-time we will incur indebtedness, generally
to (i) fund short-term working capital needs, (ii) refinance existing
indebtedness or (iii) fund major capital expenditures or the acquisition of
other assets outside the ordinary course of business. We will also
from time-to-time sell assets outside the ordinary course of business, the
proceeds of which are generally used to (i) repay existing indebtedness, (ii)
make investments in marketable and other securities, (iii) fund major capital
expenditures or the acquisition of other assets outside the ordinary course of
business or (iv) pay dividends.
Pricing
within the TiO2 industry
is cyclical, and changes in industry economic conditions significantly impact
earnings and operating cash flows. Changes in TiO2 pricing,
production volumes and customer demand, among other things, could significantly
affect our liquidity.
We
routinely evaluate our liquidity requirements, alternative uses of capital,
capital needs and availability of resources in view of, among other things, our
dividend policy, our debt service and capital expenditure requirements and
estimated future operating cash flows. As a result of this process,
we have in the past and may in the future seek to reduce, refinance, repurchase
or restructure indebtedness, raise additional capital, repurchase shares of our
common stock, modify our dividend policy, restructure ownership interests, sell
interests in our subsidiaries or other assets, or take a combination of these
steps or other steps to manage our liquidity and capital
resources. Such activities have in the past and may in the future
involve related companies. In the normal course of our business, we
may investigate, evaluate, discuss and engage in acquisition, joint venture,
strategic relationship and other business combination opportunities in the
TiO2
industry. In the event of any future acquisition or joint
venture opportunity, we may consider using then-available liquidity, issuing our
equity securities or incurring additional indebtedness.
In 2009,
we reduced our production levels in response to the current economic
environment, which has favorably impacted, and we believe will continue to
favorably impact, our liquidity by reducing our inventory levels and
expenditures. We expect to continue to have reduced capacity
utilization levels for the remainder of 2009. This will continue to
have a negative impact on our 2009 results of operations due to the resulting
fixed production costs that will be charged to cost of sales as
incurred.
At March
31, 2009, unused credit available under all of our existing credit facilities
was approximately $72.6 million, consisting principally of $39.2 million under
our European credit facility, $13.7 million under our Canadian credit facility
and $19.7 million under our U.S. credit facility. Based upon our
expectation for the TiO2 industry
and anticipated demands on cash resources, we expect to have sufficient
liquidity to meet our future obligations including operations, capital
expenditures and debt service for the next 12-months. In this regard,
see the discussion above in “Outstanding debt obligations.” We
currently are unable to borrow the unused availability under our European
revolver while we seek the amendment to such facility, as discussed
above. If actual developments differ from our expectations, our
liquidity could be adversely affected.
Capital
expenditures
We intend
to spend approximately $29 million for major improvements and upgrades to our
existing facilities during 2009, including the $11.4 million we have spent
through March 31, 2009. Compared to 2008, we have lowered our planned
capital expenditures in 2009 in response to the current economic
conditions.
Off-balance
sheet financing
We do not
have any off-balance sheet financing agreements other than the operating leases
discussed in our 2008 Annual Report.
Commitments
and contingencies
See Notes
7 and 10 to the Condensed Consolidated Financial Statements for a description of
certain income tax examinations currently underway and legal
proceedings.
Recent
accounting pronouncements
See Note 12 to the Condensed
Consolidated Financial Statements.
Critical
accounting policies
For a discussion of our critical
accounting policies, refer to Part I, Item 7 - “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” in our 2008 Annual
Report. There have been no changes in our critical accounting
policies during the first three months of 2009.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET
RISK
We are exposed to market risk,
including currency exchange rates, interest rates and security
prices. For a discussion of such market risk items, refer to Part I,
Item 7A. - “Quantitative and Qualitative Disclosure About Market Risk” in our
2008 Annual Report. There have been no material changes in these
market risks during the first three months of 2009.
We have substantial operations located
outside the United States for which the functional currency is not the U.S.
dollar. As a result, the reported amounts of our assets and
liabilities related to our non-U.S. operations, and therefore our consolidated
net assets, will fluctuate based upon changes in currency exchange
rates.
Certain
of our sales generated by our non-U.S. operations are denominated in U.S.
dollars. We periodically use currency forward contracts to manage a very
nominal portion of currency exchange rate risk associated with trade receivables
denominated in a currency other than the holder's functional currency or similar
exchange rate risk associated with future sales. We have not entered into
these contracts for trading or speculative purposes in the past, nor do we
currently anticipate entering into such contracts for trading or speculative
purposes in the future. See Note 11 to our Condensed Consolidated
Financial Statements.
ITEM
4. CONTROLS AND PROCEDURES
Evaluation
of disclosure controls and procedures
We
maintain a system of disclosure controls and procedures. The term
"disclosure controls and procedures," as defined by Exchange Act Rule 13a-15(e),
means controls and other procedures that are designed to ensure that information
required to be disclosed in the reports that we file or submit to the SEC under
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is
recorded, processed, summarized and reported, within the time periods specified
in the SEC's rules and forms. Disclosure controls and procedures
include, without limitation, controls and procedures designed to ensure that
information we are required to disclose in the reports we file or submit to the
SEC under the Exchange Act is accumulated and communicated to our management,
including our principal executive officer and our principal financial officer,
or persons performing similar functions, as appropriate to allow timely
decisions to be made regarding required disclosure. Each of Steven L.
Watson, our Chief Executive Officer, and Gregory M. Swalwell, our Vice
President, Finance and Chief Financial Officer, have evaluated the design and
operating effectiveness of our disclosure controls and procedures as of March
31, 2009. Based upon their evaluation, these executive officers have
concluded that our disclosure controls and procedures are effective as of March
31, 2009.
Internal
control over financial reporting
We also
maintain internal control over financial reporting. The term
“internal control over financial reporting,” as defined by Exchange Act Rule
13a-15(f), means a process designed by, or under the supervision of, our
principal executive and principal financial officers, or persons performing
similar functions, and effected by our board of directors, management and other
personnel, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, and includes those policies and procedures
that:
·
|
Pertain
to the maintenance of records that in reasonable detail accurately and
fairly reflect the transactions and dispositions of our
assets,
|
·
|
Provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP, and that our
receipts and expenditures are being made only in accordance with
authorizations of our management and directors,
and
|
·
|
Provide
reasonable assurance regarding prevention or timely detection of an
unauthorized acquisition, use or disposition of our assets that could have
a material effect on our Condensed Consolidated Financial
Statements.
|
As
permitted by the SEC, our assessment of internal control over financial
reporting excludes (i) internal control over financial reporting of our equity
method investees and (ii) internal control over the preparation of our financial
statement schedules required by Article 12 of Regulation
S-X. However, our assessment of internal control over financial
reporting with respect to our equity method investees did include our controls
over the recording of amounts related to our investment that are recorded in our
Condensed Consolidated Financial Statements, including controls over the
selection of accounting methods for our investments, the recognition of equity
method earnings and losses and the determination, valuation and recording of our
investment account balances.
Changes
in internal control over financial reporting
There has
been no change to our internal control over financial reporting during the
quarter ended March 31, 2009 that has materially affected, or is reasonably
likely to materially affect, our internal control over financial
reporting.
Part
II. OTHER INFORMATION
Item
1. Legal
Proceedings
Refer to Note 10 of the Condensed
Consolidated Financial Statements and to our 2008 Annual Report for descriptions
of certain legal proceedings.
Item
1A. Risk
Factors
For a discussion of the risk factors
related to our businesses, refer to Part I, Item 1A., “Risk Factors,” in our
2008 Annual report. There have been no material changes to such risk
factors during the three months ended March 31, 2009.
Item
6. Exhibits
|
31.1
- Certification
|
|
31.2
- Certification
|
|
32.1
- Certification
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Kronos
Worldwide,
Inc. (Registrant)
Date
May 6,
2009
|
/s/ Gregory M. Swalwell
|
|
Gregory
M. Swalwell
|
||
Vice
President, Finance and Chief Financial Officer
(Principal
Financial Officer)
|
||
Date
May 6,
2009
|
/s/ Tim C.
Hafer
|
|
Tim
C. Hafer
|
||
Vice
President and Controller
(Principal
Accounting Officer)
|